B2B ad examples

The BioProtect Balloon Spacer delivers consistent separation from the base to the apex of the prostate. Discover BioProtect, the Apex of Spacing for prostate cancer radiation therapies.

New today from Curi Bio: two iPSC-derived disease cell models, three assay-ready casting kits, and four expert-delivered research services. See what's new in the Curiverse™.

Rare disease research needs human biology. Curi Bio's XLMTM model is the first commercially available iPSC-derived platform for MTM1 research in 3D muscle tissue.

Introducing Uncharted: The Science Behind Women's Health, a new podcast from Allergy Research Group® for practitioners and anyone curious about the science of women’s health. In each episode, host Dr. Lara Zakaria sits down with a clinician, researcher or women’s health expert to unpack one question, connect the dots and make the conversation useful in practice and everyday life. The focus for Season 1 is women’s thyroid health. We hope you join us. Episode one is live today, with new episodes weekly. Watch the trailer to learn more, then subscribe on your preferred podcast platform to listen to the latest episode. The information shared in this podcast is for educational purposes only and is not intended to replace individualized medical advice, diagnosis, or treatment.

A CRISPR edit is only useful if the final clone is ready for downstream work. See how Applied StemCell combines project design, editing, and validation to deliver cell lines built around your experimental needs.

𝗢𝘄𝗻 𝗔 𝗕𝗲𝘁𝘁𝗲𝗿 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗜𝗻 𝗛𝗼𝗺𝗲 𝗖𝗮𝗿𝗲 𝗙𝗿𝗮𝗻𝗰𝗵𝗶𝘀𝗲 Built for 300K+ Population Territories | $90B+ Industry & Growing! Distinctive and Proven Multiple Revenue Streams: ✔️ Non-Medical Home Care ✔️ Placement & Care Management ✔️ Facility & Supplemental Staffing ✔️ Skilled Nursing Option *FDD Item 19

Every major industry runs on infrastructure. Healthcare should be no different. Learn how Cotiviti is connecting the data, workflows, and decisions that keep healthcare moving.

La rentabilidad de una clínica médica o estética depende de un equilibrio preciso entre la eficiencia administrativa y optimización del tiempo de consulta o producción médica. 🩺📈 Digitalizar la reserva y gestión de citas médica, puede transformar tu clínica: 🔹 Para la experiencia del paciente: Un proceso de agendamiento ágil, autónomo y disponible las 24 horas desde cualquier dispositivo, adaptado a la inmediatez que exige el perfil paciente actual. 🔹 Para la gestión del equipo: Reducción del volumen de llamadas entrantes, permitiendo que el personal de recepción se enfoque en la atención presencial de alto valor y en el seguimiento de presupuestos. 🔹 Para la dirección de la clínica: Captación continua de demanda fuera del horario comercial, minimización del ausentismo y mayor retorno de la inversión operacional. Optimiza tus procesos de gestión, incrementa la tasa de conversión y sitúa tu clínica a la vanguardia operativa del sector. Descubra en una sesión estratégica de 30 minutos cómo flowww puede escalar la rentabilidad de su consulta. 📲 Agende su demo personalizada aquí. > https://lnkd.in/dawjFux8/?utm_campaign=Flowww-ClientespotencialesWeb&utm_source=linkedin&utm_medium=paid&utm_id=1209690183&hsa_acc=552700966&hsa_cam=1209690183&hsa_grp=880850133&hsa_ad=1559030083&hsa_net=linkedin&hsa_ver=3

En el sector sanitario y estético, el tiempo del especialista es el activo más valioso. Sin embargo, la saturación por tareas administrativas, llamadas repetitivas y gestión de agenda limita el crecimiento de tu clínica. La tecnología no reemplaza la atención humana: la potencia. Delegar la operativa en un software integral permite al profesional centrarse en lo que realmente importa: escuchar y cuidar al paciente. Con flowww, optimizas la eficiencia operativa de tu clínica en cada etapa: 📊 Gestión y recepción eficiente: Reservas online 24/7 y recordatorios automáticos por WhatsApp que reducen drásticamente el absentismo y liberan a tu equipo. 🩺 Consulta digitalizada: Historias clínicas en la nube, cero papel y presupuestos claros que aumentan la conversión de tratamientos. ⭐ Fidelización continua: Automatización de seguimiento post-tratamiento para asegurar la máxima recurrencia y reputación médica. Gana eficiencia, maximiza la rentabilidad y ofrece la experiencia de salud que tus pacientes merecen. Agenda una sesión personalizada con uno de nuestros consultores en solo 30 minutos ⏱️ 📅 Solicita tu demo en el enlace. https://lnkd.in/dawjFux8/?utm_campaign=Flowww-ClientespotencialesWeb&utm_source=linkedin&utm_medium=paid&utm_id=1209690183&hsa_acc=552700966&hsa_cam=1209690183&hsa_grp=880850133&hsa_ad=1558902113&hsa_net=linkedin&hsa_ver=3

Laatu syntyy kodeissamme asukkaiden pienistä suurista hetkistä, jotka tekevät elämästä merkityksellisen. Se on asukkaan tuntemista, kuulemista ja näkemistä. Jokainen haluaa olla tärkeä osa yhteisöä. Niin asukas kuin henkilöstökin. Terveyden ja hyvinvoinnin laitoksen tutkimuksessa 14 Attendo-kotia sai oman alueensa parhaat arviot. ONNEA tunnustuksesta 🤩. Meillä Läntinen-Keskinen alueella kärkisijoituksille nousi 5 kotia: Omenapuisto Vaasasta, Retkonkihovi Forssasta, Joenrinne Laitilasta, Stenius Raumalta sekä Majakkatupa Luvialta. Lämpöiset onnittelut kodeille ❤️ Olen niin ylpeä teistä! Samaan aikaan olen ylpeä myös kaikissa muissa kodeissa tehtävästä vaativasta, mutta antoisasta työstä! Hyvä meidän joukkue!!!

Watch Aiforia's webinar to learn more about Aiforia® Breast Cancer Suite, the most comprehensive AI toolkit for breast cancer diagnostics, supporting the entire diagnostic workflow. What you'll see: 🟣 How AI technology can enhance precision, speed, and diagnostic accuracy in breast cancer diagnostics. 🟣 A typical BC workflow with and without AI. 🟣 How Aiforia’s AI seamlessly integrates to enhance every step, from sample analysis to diagnosis. Get the recording. 👇🏼

In Aiforia's recent webinar, Pathologist Richard Doughty discussed how a pathologist and AI can work together and shared a practical view of what good AI–pathologist collaboration actually looks like. Watch the recording. ⬇️

Minun tämän viikon työpäivien teema on kiteytynyt aika pitkälti seuraavaan lauseeseen: Koti syntyy joka päivä – teoista ja kohtaamisista💙 Ehkä koti ei synny vielä siitä, että omat valokuvat löytyvät seinältä, tutut tavarat ovat ympärillä ja nimi omassa ovessa. Kodin täytyy myös tuntua kodilta. Tämä tunne syntyy mielestäni siitä, että aamulla vastassa on tuttu ihminen. Siitä, että joku tietää, miten juuri minä haluan kahvini juoda. Että minua kuunnellaan, toiveeni tunnetaan ja saan elää oman näköistäni elämää. Ennen kaikkea siitä, että minun on hyvä ja turvallinen olla💙 Me Attendolla puhumme paljon siitä, että olemme ennen kaikkea koti. Mielestäni meidän on tärkeää välillä pysähtyä miettimään, mitä se oikeastaan tarkoittaa. Paikka, johon me tulemme töihin, on meille työpaikka. Asukkaalle se on koti. Siellä eletään tavallista elämää. Herätään aamuihin, juodaan kahvit, nauretaan, surraan, jopa itketään ja ollaan vihaisiakin. Odotetaan läheisiä kylään ja eletään niitä pieniä hetkiä, joista elämä lopulta muodostuu. Siksi yksi tärkeimmistä hetkistä ja onnistumisista on se, kun Attendo-koti alkaa tuntua myös asukkaasta omalta kodilta. THL:n asiakastyytyväisyyskyselyssä 14 Attendo Suomi kotia sijoittui oman alueensa parhaiten arvioitujen joukkoon, ja Vaasan Attendo Omenapuisto myös koko maan parhaiden joukkoon. Tulos ilahduttaa. Mutta vielä enemmän minua ilahduttaa se, mistä arvio muodostuu: asukkaiden omasta kokemuksesta. Siitä, että arki tuntuu turvalliselta, apua saa silloin kun sitä tarvitsee ja omat toiveet tulevat kuulluiksi. Ja ennen kaikkea siitä, että asukas kokee voivansa elää oman näköistään elämää omassa kodissaan. Aika perustavanlaatuisia asioita, kun miettii, mistä hyvä koti syntyy. En ajattele, että tällainen tulos tarkoittaisi sitä, että olemme valmiita. Koti ei oikeastaan koskaan tule valmiiksi. Se rakennetaan joka päivä uudelleen kohtaamisissa, teoissa ja pienissä arjen hetkissä. Näissä 14 kodissa asukkaamme ovat kertoneet meille jotain tärkeää: Olemme hyvällä matkalla kodiksi. Haluan sanoa lämpimän ja aidon kiitoksen jokaiselle attendolaiselle jokaisessa Attendo-kodissa. Tiedän, kuinka paljon hyvää työtä kodeissamme tehdään joka ikinen päivä sen eteen, että asukkaamme saavat elää juuri oman näköistään elämää omassa kodissaan. Useimmiten se työ näkyy pieninä tekoina ja kohtaamisina, joista hyvä ja turvallinen arki rakentuu. Sillä meille se on työpaikka. Asukkaalle se on elämää❤️

💡 En endoscopie, l’image ne devrait pas s’arrêter à son acquisition. Les images et vidéos produites lors d’un examen endoscopique constituent une source d’information précieuse pour les équipes médicales. Pourtant, leur potentiel reste encore largement sous-exploité lorsqu’elles ne sont pas facilement accessibles et intégrées au système d’information de l’établissement. 🖥️ Avec le moniteur Ambu® aView™ 2 Advance, l’intégration des données endoscopiques au dossier patient est simplifiée grâce à : 🔹 L’accès en temps réel aux informations patient grâce à la Worklist 🔹 L’archivage simplifié des images et vidéos directement dans le PACS ou sur un dossier local (SMB) Une intégration qui permet notamment de : 🔹 Faciliter la comparaison des examens et le suivi de l’évolution des pathologies, notamment lors des RCP 🔹 Simplifier le partage des données entre experts, y compris à distance 🔹 Rendre les images accessibles tout au long du parcours de soin du patient Le tout dans le respect des exigences de cybersécurité applicables aux établissements de santé. Chez Ambu, nous vous accompagnons gratuitement à chaque étape de votre projet de connexion, de l’installation à la formation des équipes, pour faciliter une adoption rapide et efficace de la digitalisation de vos données endoscopiques. 💬 Vous souhaitez échanger sur l’intégration de vos données endoscopiques ? Contactez-nous : [email protected]

Boniser is: Quality and process rigor. 🏅🌱 Driven by a continuous improvement approach, our Quality Management System ensures that every step of our operations delivers reliable, safe, and fully compliant botanical raw materials. From strict adherence to food safety standards to organic agronomic practices, we are committed to providing high-quality ingredients that meet verified regulatory and customer requirements. Discover more: 🔗 https://boniser.com/ #Boniser #NatureOurOnlyInspiration

PRRC: The Hidden Champions of MDR Manufacturers Every medical device manufacturer under MDR must appoint a Person Responsible for Regulatory Compliance (PRRC). Sounds simple? In reality, this role is one of the most critical and high-stakes positions in regulatory affairs. Who qualifies as a PRRC? What are their exact responsibilities? And most importantly, what are the personal risks? Let’s analyse it. 1. What is a PRRC? ↳ A legally required role overseeing MDR compliance. ↳ Manages regulatory, quality, and vigilance activities. ↳ Mandatory for manufacturers and certain authorized representatives. 2. Minimum Requirements to Become a PRRC ↳ Degree + 1 year of experience in regulatory or quality. ↳ Or 4 years of professional experience in medical devices. ↳ Experience must be specific to MDR-related tasks. 3. Key Responsibilities of a PRRC ↳ Confirms product compliance before market release. ↳ Maintains and reviews technical documentation. ↳ Oversees post-market surveillance and vigilance. 4. Internal vs. External PRRC ↳ Internal PRRC is required for most manufacturers. ↳ Small companies (<50 employees or <€10M) may outsource. ↳ External PRRC must be permanently available. 5. PRRC Personal Liability ↳ PRRCs are usually not personally accountable for compliance failures. ↳ Liability depends on contracts and national laws. ↳ Clear documentation is key to protecting oneself. A skilled PRRC plays a crucial role in regulatory success. They make sure compliance is always maintained. Products are only released when they fully meet safety and quality standards. Post-market risks are continuously monitored and managed. The PRRC isn’t just a title. It’s the company’s regulatory backbone. P.S. Does your company have an internal or external PRRC? ⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡ MedTech regulatory challenges can be complex, but smart strategies, cutting-edge tools, and expert insights can make all the difference. I'm Tibor, passionate about leveraging AI to transform how regulatory processes are automated and managed. Let's connect and collaborate to streamline regulatory work for everyone! #automation #regulatoryaffairs #medicaldevices

EU MDR and IVDR: the “special” head of the certification hydra 🐉🇪🇺 Founders often tell me the same thing: FDA feels like a path, EU feels like a puzzle. In the US you can follow one main playbook and one agency conversation. In Europe you have a regulation, guidance, standards, a Notified Body, and country-level pieces that all matter at once. It is not that the EU is impossible, it is that the roadmap is less explicit unless you build it yourself. How to turn the EU head into a usable route: ↳ Separate what is law vs what is guidance: MDR or IVDR text, then Implementing and Delegated Acts, then MDCG documents. Treat them differently in your plan. ↳ Track standards like a product dependency: watch harmonisation status (Official Journal), versions, and transition dates so you do not test to yesterday’s edition. ↳ Check if Common Specifications apply to your device category. If they do, they can change what “good enough” looks like. ↳ Build a “country overlay” sheet for your launch markets: language and labeling needs, local registration expectations, incident reporting pathways, and any extra national steps around clinical investigations. ↳ Treat clinical and data as national too: ethics submissions, site contracts, patient info sheets, and how GDPR expectations are implemented in the countries you run studies in. ↳ Ask your Notified Body what they will rely on most: which guidance, which standards, and what their sampling focus is. Document it and build to it. ↳ Maintain one living index: every guidance or national requirement you rely on, with a link, date, and where it is implemented in your QMS or tech file. ⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡ MedTech regulatory challenges can be complex, but smart strategies, cutting-edge tools, and expert insights can make all the difference. I'm Tibor, passionate about leveraging AI to transform how regulatory processes are automated and managed. Let's connect and collaborate to streamline regulatory work for everyone! #automation #regulatoryaffairs #medicaldevices

A little more courage to take the next step When business owners consider joining AddLife, we explain that our decentralised model sets clear expectations: local leaders continue to run their own businesses, drive initiatives, and maintain commercial momentum. What AddLife provides is support. One owner described it well: “We know we have to do the work. What we expect from AddLife is a little more courage.” For many family businesses, making investments on your own can feel risky. With AddLife behind you, you have room to act, learn, and move forward while staying responsible for your company. This is especially relevant for manufacturing companies with proprietary products, where long-term ownership can help protect what makes the business unique while supporting the next phase of growth. “That combination can give entrepreneurial companies the confidence to invest, develop and grow over time,” says Therese Wilson, Vice President, Homecare at AddLife. Therese’s practical, people-first approach reflects how AddLife supports business owners: with respect for the company, its people, and what they've already built. #AddLife #Entrepreneurship #LifeScience #OwnershipTransition #BusinessGrowth #AddLifeFamily #Manufacturing #ProprietaryProducts

Could you say today what your Joint Clinical Assessment will need before you file with EMA? If you had to think, you are not behind. You have found a question worth asking now, rather than at Day 120. In 30 minutes, a senior AzurBio advisor asks the questions EMA will ask and points out what you may not have seen yet. Complimentary, no preparation needed.

Before your EU strategy turns into budgets, timelines and a first EMA meeting, it deserves one outside read. In 30 minutes, a senior AzurBio advisor who has led EU launches goes through it with you: what EMA is likely to ask, what may need another look, what to do first. Complimentary, no preparation needed.

Health businesses lose the customer when a blood test is referred out. With Aniva, the order, the kit and the result stay in your platform.

ESMO - European Society for Medical Oncology ESMO 2026: One Symposium. The Full Cancer Care Continuum. From earlier cancer detection to precision oncology — treatment-response assessment, molecular recurrence monitoring, immunogenetic discovery, and functional tumour modelling, liquid biopsy and multi-omic technologies are opening new possibilities across cancer care. Join us at the Gene Solutions Industry Satellite Symposium during ESMO Congress 2026: AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation Together with international experts, the symposium will bring diverse scientific and clinical perspectives across the cancer care continuum: - Clinical challenges and unmet needs shaping the next generation of multi-cancer early detection - Technology principles, large validation datasets, and implementation pathways for AI-enabled multi-omic cfDNA profiling - An integrated precision-oncology approach using multi-omic liquid biopsy: Asian real-world evidence, and high-precision applications from integrated tissue genomic and transcriptomic profiling to longitudinal tumor informed and naive liquid biopsy monitoring for molecular residual disease and treatment response to the detection of emerging resistance mutations - The role of multi-omic signals in next-generation precision oncology and immunogenetic discovery — integrating genomic, transcriptomic, and immune readouts to characterise neoantigen profiles, the tumour microenvironment, and immune-checkpoint expression, and to support immunotherapy biomarker discovery and neoantigen vaccine development - The potential of patient-derived 3D tumor organoids to add a functional dimension to precision oncology 📅 Friday, 23 October 2026 🕘 09:45–11:15 CEST 📍 Salamanca Auditorium, Hall 10, IFEMA Madrid 🔗 Register to receive symposium updates: https://lnkd.in/gNAtBb5D 🔗 Read the symposium announcement: https://lnkd.in/dfw2jFmW 🔗 View the session in the ESMO programme: https://lnkd.in/dGWkW9Um Stay tuned as we introduce the international experts joining the symposium and share their perspectives on the future of multi-omic cancer care. #ESMO26 #LiquidBiopsy #PrecisionOncology #MultiOmics #MCED #ctDNA #MRD #GenomicProfiling #Organoids #RealWorldEvidence This non-promotional medical educational symposium is organized and funded by Gene Solutions for healthcare professionals only.

Leading professional societies have called for wider adoption of Enhanced Radiation Protection Devices (ERPDs). See how Zero-Gravity® helps interventional cardiologists, electrophysiologists and cath lab teams address radiation exposure and orthopedic strain.

Your patient is preparing to go home after a catastrophic injury. Who is coordinating what comes next? Feinberg Consulting provides independent, clinically guided catastrophic injury case management to help coordinate care across providers and settings, from acute care and inpatient rehabilitation to outpatient therapies and the home environment. We are currently accepting new catastrophic injury case management referrals, including Michigan Auto No-Fault cases. If you are supporting a patient who may benefit from coordinated case management, click “Learn More” to connect directly with our team and discuss the referral.